AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimipack M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Koye Pharmaceuticals Pvt ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimipack M 1mg/500mg Tablet

Diabexe Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can lead to elevated glucose levels and potentially serious complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight control as directed by your doctor. Lifestyle adjustments are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended by your physician.

Uses of Glimipack M 1mg/500mg Tablet

Managing Type 2 diabetes

Major Benefits of Glimipack M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimipack M 1mg/500mg Tablet with a meal.

Common Side effects of Glimipack M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimipack M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimipack M 1mg/500mg tablets with a meal.

How Glimipack M 1mg/500mg Tablet works:

Glimepiride and Metformin, combined as Glimipack M 1mg/500mg tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimipack M 1mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimipack M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimipack M 1mg/500mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimipack M 1mg/500mg tablets, potentially requiring dosage modification. Physician consultation is essential. Glimipack M 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimipack M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimipack M 1mg/500mg Tablet :

Should you forget to take your Glimipack M 1mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glimipack M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimipack M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimipack M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Glimipack M and seek immediate medical attention.
Glimipack M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimipack M 1mg/500mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimipack M 1mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimipack M 1mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimipack M 1mg/500mg Tablet with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimipack M 1mg/500mg Tab...
60
MRP 73
17% off